Categories: HealthcareNews

Teladoc Health to Announce Third Quarter 2023 Financial Results

PURCHASE, NY, Oct. 11, 2023 (GLOBE NEWSWIRE) — Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release third quarter 2023 results on Tuesday, October 24, 2023, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day.

Conference Call Details
The conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 612441. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/events/global-numbers?confId=55509. A live audio webcast will also be available online at https://ir.teladoc.com/news-and-events/events-and-presentations/.

A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Teladoc Health
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Teladoc Health leverages more than two decades of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit www.teladochealth.com or follow @TeladocHealth on Twitter.

Investors:
Patrick Feeley
914-265-7925
IR@teladochealth.com

 

Staff

Recent Posts

American College of Osteopathic Family Physicians Conclave of Fellows Welcomes 2024 Class

CHICAGO, IL / ACCESSWIRE / April 5, 2024 / The American College of Osteopathic Family…

1 day ago

Defence Therapeutics Announces Warrant Terms Amendment

Vancouver, British Columbia--(Newsfile Corp. - April 5, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB:…

1 day ago

Tidepool Achieves SOC 2 Type II Compliance

PALO ALTO, Calif.--(BUSINESS WIRE)--#DiabetesData--Tidepool, a software company committed to innovations in diabetes management, is thrilled…

1 day ago

Pathways Hospice Names Dr. Nathaniel Chappelle, M.D. as Medical Director

FORT COLLINS, CO / ACCESSWIRE / April 5, 2024 / Pathways Hospice recently named Dr.…

2 days ago

All Care Therapies Expands Pediatric Services With Acquisition of Therapy Blocks

LAS VEGAS, NV / ACCESSWIRE / April 5, 2024 / All Care Therapies, a leading…

2 days ago